From: Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer
Cell line
Treatment
HCC-1954
MDA-MB-453
HCC-202
CI-1040, μM
5
10
CI values FLU 20, μM
0.7
0.75
0.6
CI values FLU 30, μM
0.8
0.65